Завершено
Фаза III
Россия
Rituximab · Arbeitsgemeinschaft medikamentoese Tumortherapie
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation Alone in Patients With Aggressive B-cell Lymphoma: NHL-13